Eliene Smith

Develop and execute audits within finance, SOX compliance and centralized corporate support functions, including business continuity management, human resources, anti-money laundering, anti-fraud, regulatory risk, ITGC risk and controls, and corporate security.

• Engaged with management in key business processes and functions to proactively identify and mitigate risk of non-compliance with the SOX Act.
• Monitored and addressed control deficiencies recommending control enhancements for deficiencies identified.
• Coordinated resources and ensured on-schedule delivery of audit reports and memos.
• Developed relationships with senior management, represented audit department in committee meetings, and proactively monitored emerging risks and trends.
• Report to the Audit Committee Board of Director on SOX Compliance, Risk assessment, Enterprise Risk Management, audits strategy, audit results and findings remediation.
• Support Board of Directors, Audit Committee, Compensation Committee, Governance and Nominating Committee, Environmental, Social, and Governance Committee, on proactively identify and mitigate risk of non-compliance with government agencies, company's compliance program as well external entities.
• Business partner attitude and ability to collaborate effectively with different functions and culturally diverse individuals at multiple levels within the organization.
• Created and Managed a team in the completion of all audit projects, ensuring that objectives, scope, and related risks have been adequately addressed.
• Develop an innovated and motivated team providing helpful feedback and assisting in their professional development.
• Generic Drug Manufacturing and Distribution Company [NYSE: LCI]

Led audit program, assessing risk and control environments among various business units.

• Executed various current-year audit activities, including annual audit plan, risk assessment, staff resourcing, scheduling, recruiting, department, affiliate, external training programs, presentations, and ancillary projects.
• Challenged status quo and identified new business risks, leveraging identification of new and evolving risks across enterprise toward annual risk assessment while updating dynamic, risk-based audit plan.
• Managed multiple projects and competing priorities, while working independently with speed and accountability, in a hands-on manner.
• Served as Subject Matter Expert providing training for team members and stakeholders.
• Managed IT systems implementation risks, testing and compliance implications.
• Participated in LCI's $1.1 billion merger and acquisition of Kremers Urban Pharmaceuticals, leading SOX compliance implementation, SAP system integrations, HR system integration as well as compliance, risk and controls analysis.
• Lead a team of 16 internal and outsourced consultants in various aspects of the M&A effort.
• Generic Drug Manufacturing and Distribution Company [NYSE: LCI]

Responsible for ensuring proper Risk Management with global internal controls and system, ERM Risk Assessment, Global Insurance Compliance.

• Act as a business partner with stakeholders throughout the organization to ensure an effective and efficient control structure is in place in a rapidly changing environment and to assess whether the company has gaps in the Risk Environment designing solutions to lead an environment of pharmaceutical compliance, HIPPA, IT/Cybersecurity, SOX, Medicare/Medicaid, Finance GAP compliance throughout the global organization.
• Pharmaceutical Company [NYSE: AMRN]

Hired by the Audit Committee of the board of directors to develop LCI's internal audit department and take over outsourced internal audit function.

• Developed and maintained strong internal audit team and contributed to people initiatives, including recruiting, retaining, and training audit professionals. Mentored and developed people by supervising and coaching.
• Cultivated understanding of company service offerings and actively identified opportunities to better serve management.
• Performed detailed review of higher-risk areas to ensure technical accuracy and completeness of audit work as well as gathering of sufficient and appropriate evidence, and appropriate conclusion.
• Provided thought leadership and insightful recommendations surrounding a broad range of complex issues related to business processes and controls by leveraging expertise and experience.
• Generic Drug Manufacturing and Distribution Company [NYSE: LCI]

• Worked to identify, develop, and document compliance issues and recommendations using independent judgment concerning areas reviewed.
• Developed keen understanding of regulatory requirements and subsequent changes impacting bank operations and related audit environment.
• Remained abreast of changes in business, regulatory, and accounting and control environment in which financial institution operated.
• Maintained proficiency in current accounting and audit procedures and techniques as well as changes in laws and regulations impacting bank operations.